Antitumor activity of carboplatin in the composition of a copolymer of lactic and glycolic acids
- Autores: Nikolskaya E.D.1, Zhunina O.A.1, Yabbarov N.G.1, Zenin V.A.1, Tereshchenko O.G.1, Fomicheva M.V.1, Sokol M.B.1, Lobanov A.V.2, Severin E.S.1
- 
							Afiliações: 
							- OJSC Russian Research Center for Molecular Diagnostics and Therapy
- N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences
 
- Edição: Volume 66, Nº 10 (2017)
- Páginas: 1867-1872
- Seção: Full Articles
- URL: https://journal-vniispk.ru/1066-5285/article/view/241436
- DOI: https://doi.org/10.1007/s11172-017-1959-5
- ID: 241436
Citar
Resumo
Polymer particles containing carboplatin (CPt) were developed by the inclusion of this antitumor agent in a copolymer of lactic and glycolic acids (PLGA-COOH 50/50). The polymer particles were found to have a spherical form with an average diameter not exceeding 200 nm, the ζ-potential is equal to–32.2±1 mV. The CPt-loaded polymer particles possess a cytotoxic activity against human small cell and non-small cell lung carcinoma (lines H69 and A549), as well as against mouse mammary adenocarcinoma (line Ca755). The results of the in vivo studies carried out on female mice of line C57Bl/6 with inoculated mouse melanoma of line B16 showed increasing of lifespan of the animals and inhibition of tumor growth for groups treated with the polymer particles, as compared to the animals treated with the drug substance CPt.
Sobre autores
E. Nikolskaya
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
O. Zhunina
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
N. Yabbarov
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
V. Zenin
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
O. Tereshchenko
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
M. Fomicheva
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
M. Sokol
OJSC Russian Research Center for Molecular Diagnostics and Therapy
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
A. Lobanov
N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences
														Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							4 ul. Kosygina, Moscow, 119991						
E. Severin
OJSC Russian Research Center for Molecular Diagnostics and Therapy
							Autor responsável pela correspondência
							Email: e.severin@mail.ru
				                					                																			                												                	Rússia, 							8 Simferopolsky bulvar, Moscow, 117638						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					